1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nimodipine in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nimodipine) | Trials (nimodipine) | Recent Studies (post-2010) (nimodipine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 2,936 | 317 | 597 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | nimodipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 0.11 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.19 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 1.736 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 3.38 | |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | 0.0298 | |
| Voltage-dependent L-type calcium channel subunit beta-2 | Homo sapiens (human) | 0.0298 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 7.15 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 0.0699 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 1.243 | |
| Bile acid receptor | Homo sapiens (human) | 8.96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckalew, VM; Handa, RK; Strandhoy, JW | 1 |
| Bi, MZ; Gao, Z; Liu, XH; Pei, LN; Zhang, H; Zhu, J | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nimodipine
| Article | Year |
|---|---|
Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Calcium Channel Blockers; Dopamine Antagonists; Dose-Response Relationship, Drug; Furans; Gallic Acid; Haloperidol; Hematocrit; Male; Nimodipine; Platelet Activating Factor; Potassium Chloride; Rats; Rats, Inbred Strains; Renal Circulation; Vasoconstriction | 1991 |
Clinical efficacy of mouse nerve growth factor plus nimodipine in neonatal intracranial hemorrhage and its effect on plasma PAF, CNP, MMP-2, and neurological function.
Topics: Animals; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Intracranial Hemorrhages; Matrix Metalloproteinase 2; Mice; Natriuretic Peptide, C-Type; Nerve Growth Factor; Nimodipine; Platelet Activating Factor; Retrospective Studies | 2021 |